Florian Thibord

ORCID: 0000-0003-2229-8322
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genetic Associations and Epidemiology
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
  • Cancer-related molecular mechanisms research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • MicroRNA in disease regulation
  • RNA modifications and cancer
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lipid metabolism and disorders
  • Blood properties and coagulation
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Hemophilia Treatment and Research
  • Pharmacology and Obesity Treatment
  • Cardiovascular Effects of Exercise
  • Atherosclerosis and Cardiovascular Diseases
  • Epigenetics and DNA Methylation
  • Cardiovascular and exercise physiology
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiovascular Health and Disease Prevention
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • SARS-CoV-2 and COVID-19 Research
  • High Altitude and Hypoxia
  • Extracellular vesicles in disease
  • Ferroptosis and cancer prognosis

Framingham Heart Study
2020-2025

National Heart Lung and Blood Institute
2020-2025

Naval Research Laboratory Information Technology Division
2021-2025

Bordeaux Population Health
2018-2024

Université de Bordeaux
2018-2024

Karolinska Institutet
2024

Génétique Médicale & Génomique Fonctionelle
2020-2024

University of Pennsylvania
2022-2023

Framingham State University
2021-2023

Translational Therapeutics (United States)
2022

Host genetic variants influence the susceptibility and severity of several infectious diseases, discovery associations with coronavirus disease 2019 (COVID-19) phenotypes could help to develop new therapeutic strategies decrease its burden. Between May 2020 June 2021, we used COVID-19 data released periodically by UK Biobank performed 65 genome-wide association studies in up 18 releases (n = 18,481 cases 2021), hospitalization 3,260), severe outcomes 1,244), deaths 1,104), stratified sex...

10.1016/j.xhgg.2022.100095 article EN cc-by-nc-nd Human Genetics and Genomics Advances 2022-02-22

Background: Venous thromboembolism (VTE) is a life-threatening vascular event with environmental and genetic determinants. Recent VTE genome-wide association studies (GWAS) meta-analyses involved nearly 30 000 cases identified up to 40 loci associated risk, including not previously suspected play role in hemostasis. The aim of our research was expand discovery new by using cross-ancestry genomic resources. Methods: We present meta-analyzed GWAS results involving 81 669 from studies,...

10.1161/circulationaha.122.059675 article EN Circulation 2022-10-17

MicroRNAs (miRNAs) are small RNA molecules (∼22 nucleotide long) involved in post-transcriptional gene regulation. Advances high-throughput sequencing technologies led to the discovery of isomiRs, which miRNA sequence variants. While many miRNA-seq analysis tools exist, diversity output formats hinders accurate comparisons between and precludes data sharing development common downstream methods.To overcome this situation, we present here a community-based project, Transcriptomic Open Project...

10.1093/bioinformatics/btz675 article EN Bioinformatics 2019-08-28
Gerard Temprano‐Sagrera Colleen M. Sitlani William P. Bone Miguel Martín‐Bórnez Benjamin F. Voight and 95 more Alanna C. Morrison Scott M. Damrauer Paul S. de Vries Nicholas L. Smith Maria Sabater‐Lleal Abbas Dehghan Adam S. Heath Alanna C. Morrison Alex P. Reiner Andrew D. Johnson Anne Richmond Annette Peters Astrid van Hylckama Vlieg Barbara McKnight Bruce M. Psaty Caroline Hayward Cavin Ward‐Caviness Christopher J. O’Donnell Daniel I. Chasman David P. Strachan David‐Alexandre Trégouët Dennis O. Mook‐Kanamori Dipender Gill Florian Thibord Folkert W. Asselbergs Frank W.G. Leebeek Frits R. Rosendaal Gail Davies Georg Homuth Gerard Temprano Harry Campbell Herman A. Taylor Jan Bressler Jennifer E. Huffman Jerome I. Rotter Jie Yao James F. Wilson Joshua C. Bis Julie Hahn Karl C. Desch Kerri L. Wiggins Laura M. Raffield Lawrence F. Bielak Lisa R. Yanek Marcus E. Kleber Maria Sabater‐Lleal Martina Mueller Maryam Kavousi Massimo Mangino Melissa Liu Michael R. Brown Matthew P. Conomos Min‐A Jhun Ming‐Huei Chen Moniek P.M. de Maat Nathan Pankratz Nicholas L. Smith Patricia A. Peyser Paul Elliot Paul S. de Vries Peng Wei Philipp S. Wild Pierre‐Emmanuel Morange Pim van der Harst Qiong Yang Ngoc‐Quynh Le Riccardo E. Marioni Rui‐Fang Li Scott M. Damrauer Simon R. Cox Stella Trompet Stephan B. Felix Uwe Völker Weihong Tang Wolfgang Köenig J. Wouter Jukema Xiuqing Guo Sara Lindström Lu Wang Erin N. Smith William Gordon Astrid van Hylckama Vlieg Mariza de Andrade Jennifer A. Brody Jack Pattee Jeffrey Haessler Ben Brumpton Daniel I. Chasman Pierre Suchon Ming‐Huei Chen Constance Turman Marine Germain Kerri L. Wiggins James W. MacDonald Sigrid K. Brækkan

BackgroundMulti‐phenotype analysis of genetically correlated phenotypes can increase the statistical power to detect loci associated with multiple traits, leading discovery novel loci. This is first study date comprehensively analyze shared genetic effects within different hemostatic and between these their disease outcomes.ObjectivesTo discover associations by combining summary data traits events.MethodsSummary statistics from genome wide‐association studies (GWAS) seven (factor VII [FVII],...

10.1111/jth.15698 article EN cc-by-nc Journal of Thrombosis and Haemostasis 2022-03-14
Jennifer E. Huffman Jayna Nicholas Julie Hahn Adam S. Heath Laura M. Raffield and 95 more Lisa R. Yanek Jennifer A. Brody Florian Thibord Laura Almasy Traci M. Bartz Lawrence F. Bielak Russell P. Bowler Germán D. Carrasquilla Daniel I. Chasman Ming‐Huei Chen David Emmert Mohsen Ghanbari Jeffrey Haessler Jouke‐Jan Hottenga Marcus E. Kleber Ngoc‐Quynh Le Jiwon Lee Joshua P. Lewis Ruifang Li‐Gao Jian’an Luan Anni Malmberg Massimo Mangino Riccardo E. Marioni Ángel Martínez-Pérez Nathan Pankratz Ozren Polašek Anne Richmond Benjamin A.T. Rodriguez Jerome I. Rotter Maristella Steri Pierre Suchon Stella Trompet Stefan Weiß Marjan Zare Paul L. Auer Michael H. Cho Paraskevi Christofidou Gail Davies Eco J. C. de Geus Jean‐François Deleuze Graciela E. Delgado Lynette Ekunwe Nauder Faraday Martin Gögele Andreas Greinacher He Gao Tom E. Howard Peter K. Joshi Tuomas O. Kilpeläinen Jari Lahti Allan Linneberg Silvia Naitza Raymond Noordam Ferran Paüls-Vergés Stephen S. Rich Frits R. Rosendaal Igor Rudan Kathleen A. Ryan Juan Carlos Souto Frank J.A. van Rooij Heming Wang Wei Zhao Lewis C. Becker Andrew D Beswick Michael R. Brown Brian E. Cade Harry Campbell Kelly Cho James D. Crapo Joanne E. Curran Moniek P.M. de Maat Margaret F. Doyle Paul Elliott James S. Floyd Christian Fuchsberger Niels Grarup Xiuqing Guo Sarah E. Harris Lifang Hou Ivana Kolčić Charles Kooperberg Cristina Menni Matthias Nauck Jeffrey R. O’Connell Valeria Orrù Bruce M. Psaty Katri Räikkönen Jennifer A. Smith José Manuel Soria David J. Stott Astrid van Hylckama Vlieg Hugh Watkins Gonneke Willemsen Peter W.F. Wilson Yoav Ben‐Shlomo

10.1182/blood.2023022596 article EN Blood 2024-09-03

ABSTRACT Integrating multi‐omics data may help researchers understand the genetic underpinnings of complex traits and diseases. However, best ways to integrate use them address pressing scientific questions remain a challenge. One important topical problem is how assess aggregate effect multiple genomic types (e.g. genotypes gene expression levels) on phenotype, particularly while accommodating routine issues, such as having related subjects' in analyses. In this paper, we extend an existing...

10.1002/gepi.22610 article EN Genetic Epidemiology 2025-01-01

Abstract Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there need for improved plasma biomarker-based tools VTE diagnosis risk prediction. Here we show, using proteomics profiling to screen from patients suspected acute VTE, several case-control studies how Complement Factor H Related 5 protein (CFHR5), regulator of the alternative pathway complement activation, VTE-associated biomarker....

10.1038/s41467-023-38383-y article EN cc-by Nature Communications 2023-06-07
Paul S. de Vries Paula Reventún Michael R. Brown Adam S. Heath Jennifer E. Huffman and 90 more Ngoc‐Quynh Le Allison Bebo Jennifer A. Brody Gerard Temprano‐Sagrera Laura M. Raffield Ayse Bilge Ozel Florian Thibord Deepti Jain Joshua P. Lewis Blanca Rodríguez Nathan Pankratz Kent D. Taylor Ozren Polašek Ming‐Huei Chen Lisa R. Yanek Germán D. Carrasquilla Riccardo E. Marioni Marcus E. Kleber David‐Alexandre Trégouët Jie Yao Ruifang Li‐Gao Peter K. Joshi Stella Trompet Ángel Martínez-Pérez Mohsen Ghanbari Tom E. Howard Alex P. Reiner Marios Arvanitis Kathleen A. Ryan Traci M. Bartz Igor Rudan Nauder Faraday Allan Linneberg Lynette Ekunwe Gail Davies Graciela E. Delgado Pierre Suchon Xiuqing Guo Frits R. Rosendaal Lucija Klarić Raymond Noordam Frank J.A. van Rooij Joanne E. Curran Marsha M. Wheeler William O. Osburn Jeffrey R. O’Connell Eric Boerwinkle Andrew D Beswick Bruce M. Psaty Ivana Kolčić Juan Carlos Souto Lewis C. Becker Torben Hansen Margaret F. Doyle Sarah E. Harris Angela P. Moissl Jean‐François Deleuze Stephen S. Rich Astrid van Hylckama Vlieg Harry Campbell David J. Stott José Manuel Soria Moniek P.M. de Maat Laura Almasy Lawrence C. Brody Paul L. Auer Braxton D. Mitchell Yoav Ben‐Shlomo Myriam Fornage Caroline Hayward Rasika A. Mathias Tuomas O. Kilpeläinen Leslie A. Lange Simon R. Cox Winfried März Pierre‐Emmanuel Morange Jerome I. Rotter Dennis O. Mook‐Kanamori James F. Wilson Pim van der Harst J. Wouter Jukema M. Arfan Ikram John Blangero Charles Kooperberg Karl C. Desch Andrew D. Johnson Maria Sabater‐Lleal Charles J. Lowenstein Nicholas L. Smith Alanna C. Morrison

10.1182/blood.2023021452 article EN Blood 2024-02-06

Essentials•Platelet function testing in large populations is rare.•We performed 5 types of platelet tests on 3429 participants the Framingham Heart Study.•Different are unique, and so one cannot be substituted for another.•Sex, age, aspirin use significantly affect results, care must taken interpreting reference ranges.AbstractBackgroundAssessment key diagnosing bleeding disorders evaluating antiplatelet drug efficacy. However, there a prevailing "one-size-fits-all" approach interpretation...

10.1016/j.rpth.2024.102406 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2024-03-01

Background and Purpose- Arterial vasospasm is a well-known delayed complication of aneurysmal subarachnoid hemorrhage (aSAH). However, no validated biomarker exists to help clinicians discriminating patients with aSAH who will develop (VSP+) identifying those then deserve aggressive preventive therapy. We hypothesized that whole-blood miRNAs could be source candidate biomarkers for vasospasm. Methods- Using next-generation sequencing approach, we performed miRNA profiling between...

10.1161/strokeaha.118.021101 article EN Stroke 2018-09-01

Depression is an independent risk factor of cardiovascular disease morbidity. Serotonin a key neurotransmitter in depressive pathology, contained within platelets, and weak activator platelets. Our study assessed the link between platelet reactivity traits, depression, antidepressant (AD) use large population sample. was conducted Framingham Heart Study (n = 3,140), AD 563) aspirin 681) were noted. measured using Center for Epidemiological Studies-Depression (CES-D) survey. Platelet traits...

10.1002/cpt.2517 article EN cc-by Clinical Pharmacology & Therapeutics 2021-12-23

Abstract Platelets play a key role in thrombosis and hemostasis. Platelet count (PLT) mean platelet volume (MPV) are highly heritable quantitative traits, with hundreds of genetic signals previously identified, mostly European ancestry populations. We here utilize whole genome sequencing (WGS) from NHLBI’s Trans-Omics for Precision Medicine initiative (TOPMed) large multi-ethnic sample to further explore common rare variation contributing PLT (n = 61 200) MPV 23 485). identified replicated...

10.1093/hmg/ddab252 article EN Human Molecular Genetics 2021-09-06
David Stacey Lingyan Chen Paulina J. Stanczyk Joanna M. M. Howson Amy M. Mason and 90 more Stephen Burgess Stephen MacDonald Jonathan Langdown Harriett McKinney Kate Downes Neda Farahi James E. Peters Saonli Basu James S. Pankow Weihong Tang Nathan Pankratz Maria Sabater‐Lleal Paul S. de Vries Nicholas L. Smith Abbas Dehghan Adam S. Heath Alanna C. Morrison Alex P. Reiner Andrew D. Johnson Anne Richmond Annette Peters Astrid van Hylckama Vlieg Barbara McKnight Bruce M. Psaty Caroline Hayward Cavin Ward‐Caviness Christopher J. O’Donnell Daniel I. Chasman David P. Strachan David‐Alexandre Trégouët Dennis O. Mook‐Kanamori Dipender Gill Florian Thibord Folkert W. Asselbergs Frank W.G. Leebeek Frits R. Rosendaal Gail Davies Georg Homuth Gerard Temprano Harry Campbell Herman A. Taylor Jan Bressler Jennifer E. Huffman Jerome I. Rotter Jie Yao James F. Wilson Joshua C. Bis Julie Hahn Karl C. Desch Kerri L. Wiggins Laura M. Raffield Lawrence F. Bielak Lisa R. Yanek Marcus E. Kleber Martina Mueller Maryam Kavousi Massimo Mangino Matthew P. Conomos Melissa Liu Michael R. Brown Min-A Jhun Ming‐Huei Chen Moniek P.M. de Maat Patricia A. Peyser Paul Elliot Peng Wei Philipp S. Wild Pierre‐Emmanuel Morange Pim van der Harst Qiong Yang Ngoc‐Quynh Le Riccardo E. Marioni Ruifang Li Scott M. Damrauer Simon R. Cox Stella Trompet Stephan B. Felix Uwe Völker Wolfgang Köenig J. Wouter Jukema Xiuqing Guo Amy D. Gelinas Daniel J. Schneider Nebojša Janjić Nilesh J. Samani Shu Ye Charlotte Summers Edwin R. Chilvers John Danesh Dirk S. Paul

Abstract Many individual genetic risk loci have been associated with multiple common human diseases. However, the molecular basis of this pleiotropy often remains unclear. We present an integrative approach to reveal mechanism underlying PROCR locus, lower coronary artery disease (CAD) but higher venous thromboembolism (VTE) risk. identify -p.Ser219Gly as likely causal variant at locus and protein C a factor. Using analyses, recall-by-genotype in vitro experimentation, we demonstrate that...

10.1038/s41467-022-28729-3 article EN cc-by Nature Communications 2022-03-09

Abstract Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality, with large disparities in incidence rates between Black White Americans. Polygenic risk scores (PRSs) limited variants discovered genome-wide association studies European-ancestry samples can identify individuals at high of VTE. However, there evidence on whether high-dimensional PRS constructed using more sophisticated methods diverse training data enhance the predictive ability their utility...

10.1101/2024.01.09.24300914 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-01-10

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality, with large disparities in incidence rates between Black White Americans. Polygenic risk scores (PRSs) limited variants discovered genome-wide association studies European-ancestry samples can identify individuals at high of VTE. However, there evidence on whether high-dimensional PRS constructed using more sophisticated methods diverse training data enhance the predictive ability their utility across...

10.1093/hmg/ddae097 article EN public-domain Human Molecular Genetics 2024-06-16

Our prior genome-wide association study of thrombin-induced platelet aggregation identified a G protein-coupled receptor kinase 5 (GRK5) noncoding variant (rs10886430-G) that is strongly associated with increased reactivity to thrombin. This predisposes risk stroke, pulmonary embolism, and venous thromboembolism.

10.1016/j.rpth.2024.102556 article EN cc-by Research and Practice in Thrombosis and Haemostasis 2024-08-01

Abstract Background Alcohol consumption is linked to decreased platelet function. Whether this link dependent on sex or type of beverage remains unclear. Methods Cross-sectional data were obtained from the Framingham Heart Study (N = 3427). was assessed by using standardized medical history and Harvard semi-quantitative food frequency questionnaires. Five bioassays measured 120 reactivity traits across agonists in whole-blood platelet-rich plasma samples. Linear mixed-effects models adjusted...

10.1093/ije/dyad099 article EN public-domain International Journal of Epidemiology 2023-07-11

MicroRNAs (miRNAs) are small regulatory RNAs participating to several biological processes and known be involved in various pathologies. Measurable body fluids, miRNAs have been proposed serve as efficient biomarkers for diseases and/or associated traits. Here, we performed a next-generation-sequencing based profiling of plasma 344 patients with venous thrombosis (VT) assessed the association miRNA levels haemostatic traits risk VT recurrence. Among most significant findings, detected an...

10.1093/eurheartj/suaa008 article ES cc-by-nc European Heart Journal Supplements 2020-04-01

SUMMARY Genome wide association study (GWAS) results for Venous Thromboembolism (VTE) across 9 international cohorts of the Global Biobank Meta-analysis Initiative (GBMI), with representation six ancestry groups (cases=27,987, controls=1,035,290), were combined using inverse-variance weighted meta-analysis. This multi-ancestry GWAS resulted in 38 genome-wide significant loci, which are potentially novel. For each autosomal locus we performed gene prioritization seven independent, yet...

10.1101/2022.06.21.22276721 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2022-06-27

Next-generation sequencing is an increasingly popular and efficient approach to characterize the full set of microRNAs (miRNAs) present in human biosamples. MiRNAs' detection quantification still remain a challenge as they can undergo different posttranscriptional modifications might harbor genetic variations (polymiRs) that may impact on alignment step. We novel algorithm, OPTIMIR, incorporates biological knowledge miRNA editing genome-wide genotype data available processed samples improve...

10.1261/rna.069708.118 article EN RNA 2019-02-28

Arterial tonometry and vascular calcification measures are useful in cardiovascular disease (CVD) risk assessment. Prior studies found associations between measures, arterial calcium, CVD risk. Activated platelets release angiopoietin-1 other factors, which may connect structure platelet function. We analyzed tonometry, function, aortic, thoracic coronary abdominal aorta diameters measured the Framingham Heart Study Gen3/NOS/OMNI-2 cohorts (n = 3,429, 53.7% women, mean age 54.4 years ±9.3)....

10.1080/09537104.2023.2238835 article EN public-domain Platelets 2023-08-23
Coming Soon ...